Aurora Cancer Care, a not-for-profit health care provider in Wisconsin and northern Illinois is launching a precision medicine program powered by Syapse, a provider of precision oncology solutions. The new oncology precision medicine program will help physicians and researchers provide more care options for patients whose cancer is resistant to conventional treatment options like radiation and chemotherapy.The new multi-disciplinary Oncology Precision Medicine Clinic will be located inside
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Median Technologies and inVentiv Health Partner to Provide Medical Image Analysis for Clinical Trials
Median Technologies, the Imaging Phenomics Company, and inVentiv Health, a biopharmaceutical professional services company, announced a strategic alliance to offer biopharmaceutical clients with best-in-class medical image analysis and management services for early to late stage oncology clinical trials. The alliance will provide inVentiv clients with the most advanced imaging biomarkers, at a time when 73 percent of cancer compounds in clinical trials involve biomarkers in their research and
Read More
Comprehend Systems Lands $15M to Expand Clinical Trials Data Platform
Comprehend Systems, Inc., a provider of Clinical Intelligence solutions has raised $15 million in Series C funding led by Eminence Capital, with participation by existing investors Sequoia Capital and Lightspeed Venture Partners.The company plans to utilize the funding to aggressively expand sales and engineering to meet a growing demand for Comprehend's cloud-based software that enables Clinical Research teams to deliver an order of magnitude improvement in the speed and quality of trial
Read More
DrFirst Acquires VisibilityRx to Optimize Clinical Trial Recruitment
DrFirst, a provider of electronic prescribing, integrated medication management and secure communication for healthcare has acquired Duluth, GA-based VisibilityRx, a provider of clinical trial recruitment services to life sciences, clinical research organizations and pharmacies. Financial terms of the acquisition were not disclosed. For DrFirst, the acquisition provides 60,000 physician clients the ability to easily identify and refer their patients to the latest clinical trials and
Read More
Specimatch Launches Clinical Trial Monitoring Platform for Cancer Patients
Specimatch, a continual clinical trial monitoring service, has unveiled the web-based software service for cancer patients and oncologists. On Specimatch.com, users can easily and intuitively connect to clinical trials personally matched to the patient’s genetic and clinical profiles.Founded in 2016 by Dr. Ken Dixon, founder/surgical oncologist of Surgical Oncologists of Northeast Georgia, Specimatch.com’s interface was created to let both clinicians and patients take part in the management of
Read More
Philips, N-of-One Partner to Speed Clinical Interpretation of Cancer Genomics
Royal Philips and N-of-One, Inc., a provider of clinical interpretation of molecular tests in oncology is teaming up to enhance the capabilities of Philips’ IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips’ new precision medicine solution for oncology.This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with
Read More
American Heart Association, Amazon Launch Cloud-Based Precision Medicine Data Marketplace
The American Heart Association (AHA) has announced a strategic collaboration with Amazon Web Services (AWS) to launch a secure cloud-based precision medicine data marketplace. The marketplace will include a vast array of curated rich datasets, that are centrally stored, easily searched and accessible, and managed on the AWS cloud. This platform enables researchers and clinicians to aggregate and analyze a rich breadth and depth of data including longitudinal cohorts, proteomic, genomic, and
Read More
NantCare Unveils Solutions to Support CMS Oncology Care Model
NantCare, a member of the NantWorks will be providing community oncology practices with solutions and resources that will help these practices comply with the administrative and clinical requirements put forth by the CMS’ new Oncology Care Model (OCM). Typically only available at large cancer institutions, NantCare will provide access to clinical trials through facilitation of participation in Cancer MoonShot 2020’s QUILT Trials, eliminating the need for patients to travel to major cancer
Read More
Duke Clinic, PatientsLikeMe Launches Virtual Clinical Trial for ALS Patients
Today, PatientsLikeMe has launched a virtual clinical trial with The Duke ALS Clinic that evaluates the potential of Lunasin, a soy peptide, to reverse symptoms in ALS patients. The Lunasin Virtual Trial is the first study of the supplement in ALS patients and follows a review analyzing its potential to reverse ALS in ALSUntangled, a website for clinicians, patients and researchers to explore alternative treatments. This launch marks one of the most unusual trials in the condition's history
Read More
Medidata Launches AppConnect Partner Program to Build Apps For Clinical Trials
Medidata, a provider of cloud-based solutions for clinical research in life sciences, today announced the launch of its AppConnect Partner Program in support of mobile health (mHealth) innovation. The program combines Medidata’s cloud and mHealth technology with access to digital health firms that have extensive experience developing patient engagement tools for clinical development, such as mobile apps and remote patient research platforms.Boston Technology Corporation, LifeMap Solutions and
Read More
